Carboplatin/etoposide/ifosfamideLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1927卷 / 1期

关键词：

D O I：

10.1007/s40278-022-24890-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：154 / 154

相关论文

共 50 条

[31] Doxorubicin/ifosfamideLack of efficacy: case report
Reactions Weekly, 2023, 1967 (1) : 151 - 151
[32] Doxorubicin/ifosfamideLack of efficacy: case report
Reactions Weekly, 2023, 1965 (1) : 187 - 187
[33] Doxorubicin/IfosfamideLack of efficacy: case report
Reactions Weekly, 2025, 2044 (1) : 131 - 131
[34] Doxorubicin/ifosfamideLack of efficacy: case report
Reactions Weekly, 2022, 1915 (1) : 181 - 181
[35] Epirubicin/ifosfamideLack of efficacy: case report
Reactions Weekly, 2023, 1966 (1) : 156 - 156
[36] Carboplatin/etoposide/gefitinibAcquired resistance and lack of efficacy: case report
Reactions Weekly, 2023, 1945 (1) : 150 - 150
[37] Carboplatin/etoposide/immune-globulinLack of efficacy: case report
Reactions Weekly, 2025, 2051 (1) : 81 - 81
[38] Carboplatin/etoposide/serplulimabGastrointestinal reactions and lack of efficacy: case report
Reactions Weekly, 2024, 2037 (1) : 104 - 104
[39] Doxorubicin/ifosfamideLack of efficacy: case report
Reactions Weekly, 2023, 1949 (1) : 186 - 186
[40] Doxorubicin/ifosfamideLack of efficacy: case report
Reactions Weekly, 2022, 1936 (1) : 204 - 204

← 1 2 3 4 5 →